Market Overview

NuVasive to Release $62.5M from Escrow Following Appeals Court Win

Related NUVA
Earnings Scheduled For May 4, 2015
Canaccord Just Downgraded NuVasive And Shares Are Falling
NuVasive Tops Q1 Earnings on High Revenues; Margins Rise - Analyst Blog (Zacks)

NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today the release of $62.5 million from a restricted escrow account in relation to NuVasive's trademark dispute regarding the NeuroVision(R) trade name.

Posted-In: News Legal


Related Articles (NUVA)

Around the Web, We're Loving...

Get Benzinga's Newsletters